MedTrace Logo

Unraveling a Potential Connection Between Bilirubin Metabolism, Gut Microbiota and Inflammatory Bowel Diseases

NCT03841045 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2019-02-15

No results posted yet for this study

Summary

Inflammatory Bowel Diseases (IBDs) are a set of recurrent inflammatory conditions that include the colon and small intestine. The two principal conditions include Crohn's disease (CD) and ulcerative colitis (UC). The etiology of which is likely to stem from the interplay of gut microbial imbalances and host. In this study stool cultures, saliva and skin samples will be taken from all participants.

Conditions

  • Colitis, Ulcerative
  • Crohn Disease

Sponsors & Collaborators

  • Soroka University Medical Center

    lead OTHER

Principal Investigators

  • ARIK SEGAL, MD · SOROKA MC

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-14
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03841045 on ClinicalTrials.gov